Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JLWXW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN113943310A ADC-18
|
|||||
| Synonyms |
CN113943310A ADC-18
Click to Show/Hide
|
|||||
| Organization |
SICHUAN BAILI PHARMACEUTICAL CO. LTD.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
WO2025015586A1, ADC34, Payload
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
CN113943310A, ADC-12, Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
L-H8
|
|||||